in the Negative? (DrugWonks.com)
How should the FDA counter all of the negative media coverage that's been circling in recent months? In a short entry, blogger Peter Pitts cites examples of what's working and what's not working at the FDA.
GSK Leads the
Last week, GlaxoSmithKline (GSK) announced that it will publish detailed summaries of its clinical trials on a public website. Blogger Mark Senak praises this move, and notes that other companies should take GSK's transparency cue.
Hubub Over Transgenically-Derived Treatments (PatentBaristas.com)
The European Committee has recommended GTC Biotherapeutics' injectable antithrombin drug, ATryn, for approval. In her entry, blogger Nicole Tepe discusses the debate in the medical community regarding animal-derived antithrombin, and speculates on the progress of this type of treatment if ATryn is granted final approval.